S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine (Beijing Luzhu Biopharmaceutical)
福氏宋内氏痢疾双价结合疫苗(北京智飞绿竹)
Report date: 2026/04/03 20:03:44
Base Information
Drug NameS.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine (Beijing Luzhu Biopharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co LtdBeijing Zhifei Lvzhu Biopharmaceutical Co LtdBeijing Lvzhu Biological Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A